Cefimek (cefepime) solution powder 1g. №1

Description

Adults.
Infections caused by Cefimek susceptible microorganisms, namely:
respiratory tract infections (including hospital and non-hospital pneumonia, acute bronchitis and exacerbation of chronic bronchitis);
skin and soft tissue infections;
intra-abdominal infections (including peritonitis and biliary tract infections);
gynecological infections;
septicemia;
Empirical therapy of patients with neutropenic fever.
Prevention of postoperative complications in intra-abdominal surgery.
Children.
Pneumonia;
urinary tract infections (both complicated, such as pyelonephritis, and without complications);
skin and soft tissue infections;
septicemia;
empirical therapy of patients with neutropenic fever;
bacterial meningitis.